U.S. markets closed

Novo Nordisk A/S (NVO)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
99.66-1.75 (-1.73%)
At close: 4:00PM EDT
99.66 0.00 (0.00%)
After hours: 05:10PM EDT
Show:
Balance Sheet
Cash Flow
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

Currency in DKK. All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Breakdown
ttm
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Total Revenue
129,910,000
126,946,000
122,021,000
111,831,000
111,696,000
Cost of Revenue
22,132,000
20,932,000
20,088,000
17,617,000
17,632,000
Gross Profit
107,778,000
106,014,000
101,933,000
94,214,000
94,064,000
Operating Expense
54,031,000
51,888,000
49,450,000
46,966,000
45,097,000
Operating Income
53,747,000
54,126,000
52,483,000
47,248,000
48,967,000
Net Non Operating Interest Income Expense
2,594,000
-203,000
-436,000
-106,000
-89,000
Other Income Expense
-
-793,000
-3,494,000
473,000
-198,000
Pretax Income
55,548,000
53,130,000
48,553,000
47,615,000
48,680,000
Tax Provision
11,186,000
10,992,000
9,602,000
8,987,000
10,550,000
Net Income Common Stockholders
44,362,000
42,138,000
38,951,000
38,628,000
38,130,000
Diluted NI Available to Com Stockholders
44,362,000
42,138,000
38,951,000
38,628,000
38,130,000
Basic EPS
-
18.05
16.41
15.96
15.42
Diluted EPS
-
18.01
16.38
15.93
15.39
Basic Average Shares
-
2,333,900
2,374,299
2,419,603
2,473,218
Diluted Average Shares
-
2,340,000
2,378,658
2,424,417
2,478,093
Total Operating Income as Reported
53,747,000
54,126,000
52,483,000
47,248,000
48,967,000
Total Expenses
76,163,000
72,820,000
69,538,000
64,583,000
62,729,000
Net Income from Continuing & Discontinued Operation
44,362,000
42,138,000
38,951,000
38,628,000
38,130,000
Normalized Income
45,114,304
42,885,006
41,643,314
38,254,129
38,295,996
Interest Income
2,066,000
337,000
65,000
51,000
69,000
Interest Expense
-678,000
390,000
220,000
85,000
90,000
Net Interest Income
2,594,000
-203,000
-436,000
-106,000
-89,000
EBIT
54,870,000
53,520,000
48,773,000
47,700,000
48,770,000
EBITDA
60,973,000
-
-
-
-
Reconciled Cost of Revenue
22,132,000
20,932,000
20,088,000
17,617,000
17,632,000
Reconciled Depreciation
6,103,000
5,753,000
5,661,000
3,925,000
3,182,000
Net Income from Continuing Operation Net Minority Interest
44,362,000
42,138,000
38,951,000
38,628,000
38,130,000
Total Unusual Items Excluding Goodwill
-942,000
-942,000
-3,357,000
461,000
-212,000
Total Unusual Items
-942,000
-942,000
-3,357,000
461,000
-212,000
Normalized EBITDA
61,915,000
60,215,000
57,791,000
51,164,000
52,164,000
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-189,696
-194,994
-664,686
87,129
-46,004